Zdrowie i gospodarka · 25/11/2015

FDA Announces Public Meeting on Patient-Focused Drug Development for Psoriasis

The FDA is hosting a public meeting to gather patient perspectives on psoriasis treatment approaches and will accept public comments on the topic as part of its performance commitments under the Prescription Drug User Fee Act (PDUFA V).